These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Autologous cell based therapy for treating chronic infarct myocardium.
    Author: Tran N, Marie PY, Nloga J, Mascali F, Franken P, Lahoutte T, Li Y, Antunes L, El Jaafari A, Bensoussan D, Stoltz JF, Villemot JP.
    Journal: Clin Hemorheol Microcirc; 2005; 33(3):263-8. PubMed ID: 16215292.
    Abstract:
    Recent experimental and clinical studies have shown that autologous cell based therapy using skeletal myoblasts or bone marrow-derived stem cells might have beneficial effects in chronic ischemic heart disease. The underlying concept is based on the repopulation of necrotic tissue by either readily contractile myoblasts or by bone marrow-derived stem cells. However, there is a need to resolve a number of issues for determining the better way to perform these treatments and, moreover, for assessing the real beneficial functional effect of each of these cell therapies. In this mini-review, we will discuss (i) the issues of the selection of chronic infarct animal to truly determine the impact of cell therapy on cardiac function recovery, and (ii) the evaluation of the bio-availability and the bio-distribution of transplanted cells. Some new investigational methodologies based on clinical end-points are also proposed.
    [Abstract] [Full Text] [Related] [New Search]